1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Basic demographics, symptoms, MRI findings, and modified Rankin Scale scores of patients with neurosarcoidosis
Characteristics Total (%) DMVE (+) (%) DMVE (−) (%) P Value
No. 21 7 14 
Age (mean ± SD) (yr) 46 ± 14 45 ± 13 47 ± 16 .813
Sex (M/F) 10/11 6/1 4/10 .013^{^a}
Symptoms 
    Headache 8 (38%) 4 (57%) 4 (29%) .346
    Vision loss 5 (24%) 1 (14%) 4 (29%) .624
    Seizure 3 (14%) 0 (0%) 3 (21%) .521
    Extremity weakness 3 (14%) 1 (14%) 2 (14%) 1
    Cranial neuropathy 2 (10%) 0 (0%) 2 (14%) .533
    Gait instability 3 (14%) 2 (29%) 1 (7%) .247
    Bowel/bladder dysfunction 4 (19%) 3 (43%) 1 (7%) .088
    Others 4 (19%) 1 (14%) 3 (21%) 
Intracranial hemorrhage 
    Microhemorrhage 7 (33%) 5 (71%) 2 (14%) .009^{^a}
    Macrohemorrhage 1 (5%) 1 (14%) 0 (0%) .147
Enhancing disease 
    Leptomeningeal 13 (62%) 4 (57%) 9 (64%) .751
    Pachymeningeal 8 (38%) 3 (43%) 5 (36%) .751
    Perivascular 3 (14%) 3 (43%) 0 (0%) .008^{^a}
Venous thrombosis 2 (10%) 1 (14%) 1 (7%) .599
Hydrocephalus 6 (29%) 4 (57%) 2 (14%) .040^{^a}
Modified Rankin Scale score (mean) 
    At initial MRI (n = 20) 3.2 ± 0.75 2.1 ± 1.5 .125
    At follow-up (n = 18) 2.4 ± 1.1 1.5 ± 1.1 .167
↵a Statistically significant.